Retrospective analysis has shown that overexpression of PD-L1 in NSCLC cells indicates high invasiveness and poor prognosis: Yang et al. 13reported that pulmonary adenocarcinoma patients with high expression of PD-L1 had longer recurrence-free survival than those with low expression of PD-L1. The gene discussed is CD274; the disease is non-small cell lung carcinoma.